Concepedia

C. Birbara

CB

Statistics

Publications

29

Citations

7.1K

H-Index

24

Active since

1968

Affiliations

University of Massachusetts Chan Medical School(Current)

University of California San Diego

University Hospital Southampton NHS Foundation Trust

Swedish Medical Center

University of Washington

C. Birbara is an author at University of Massachusetts Chan Medical School specializing in pharmacotherapy, rheumatology, and medicine.

Publications per year

1968–2018

29

Publications

29

Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

Michael E. Weinblatt, Edward Keystone, Daniel E. Furst et al. · Arthritis & Rheumatism · 2003 · 1.8K citations

, , +15

Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition

Mark C. Genovese, Jean‐Claude Becker, Michael Schiff et al. · New England Journal of Medicine · 2005 · 1.2K citations · Full text

, , +16

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

Christian Antoni, Gerald G. Krueger, Kurt de Vlam et al. · Annals of the Rheumatic Diseases · 2005 · 716 citations · Full text

, , +15

Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee

Nancy E. Lane, Thomas J. Schnitzer, C. Birbara et al. · New England Journal of Medicine · 2010 · 672 citations · Full text

, , +17

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).

Daniel E. Furst, Michael Schiff, Roy Fleischmann et al. · PubMed · 2003 · 494 citations

, , +17

1–5 of 29